BIOMAT Database Logo BIOMAT Database Logo

[Our experience with using choline blockaders in treating peptic ulcer]. 1975

G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia

UI MeSH Term Description Entries
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005730 Ganglionic Blockers Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. Ganglionic Blocking Agents,Ganglioplegic Agents,Blocking Agents, Ganglionic,Ganglionic Blockaders,Agents, Ganglionic Blocking,Agents, Ganglioplegic,Blockaders, Ganglionic,Blockers, Ganglionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Our experience in treating peptic ulcer by vagotomy].
January 1968, Zhurnal eksperimental'noi i klinicheskoi meditsiny,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[OUR EXPERIENCE WITH "GEFARNIL" IN THE PEPTIC ULCER].
December 1964, Revista clinica espanola,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Gastric secretion blockaders in peptic ulcer].
January 1989, Sovetskaia meditsina,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Experience in treating peptic ulcer with accompanying chronic cholecystitis].
August 1978, Vrachebnoe delo,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Experience in using adrenergic blockaders in treating diabetes mellitus].
January 1978, Problemy endokrinologii,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Experience in treating patients with peptic ulcer exacerbation with solcoseryl and etimizol].
January 1986, Klinicheskaia meditsina,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
January 1989, Terapevticheskii arkhiv,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Experience in treating patients with peptic ulcer on the polyclinical dispensary level].
July 1959, Sovetskaia meditsina,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Diagnosis and treatment of bleeding peptic ulcer: our experience].
January 2008, La Clinica terapeutica,
G I Burchinskiĭ, and T M Galetskaia, and E A Ivanova, and L M Kaskevich, and E V Litinskaia
[Our experience in the treatment of post-anastomotic peptic ulcer with vagotomy].
October 1967, Ospedali d'Italia - chirurgia,
Copied contents to your clipboard!